XURIDEN
NDC 50633-330, uridine triacetate, granule, from BTG International Inc.
- Product NDC
- 50633-330
- Status
- Listed
- Labeler
- BTG International Inc
- Dosage form
- GRANULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208169
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50633-330 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- URIDINE TRIACETATE951 mg/g
Pharmacologic classes
Analogs/Derivatives [Chemical/Ingredient]; Pyrimidine Analog [EPC]; Pyrimidines [Chemical/Ingredient]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50633-330-30 | 50633033030 | 30 PACKET in 1 CARTON (50633-330-30) / 2 g in 1 PACKET (50633-330-02) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/88ca4d2b-3905-474b-9fd6-c81474f2fb4b
Use it
Look up 50633-330 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50633-330 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50633-330. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.